United States: In A Regulatory "One-Two," FDA Modifies Terms Of Oversight Concerning Homeopathic Drugs

Duane Morris LLP

Late last week, the FDA-in denying a citizen petition and issuing two Federal Register notices-modified published guidance on the manufacture and distribution of homeopathic drugs.

United States: Cosmetics, Hemp, And CBD: Legislative And Regulatory Update

Seyfarth Shaw LLP

Seyfarth Synopsis: Through a reintroduced House bill, Congress is taking strides to push for cosmetic regulation reform and, separatel

CMS wants to crack down on supplemental Medicaid payments

As Medicaid supplemental state payments have become a larger proportion of total program payments, the CMS wants to increase transparency and oversight of the funding.

READ MORE >